Experience

Sementis Ltd

• Australia
• Biotechnology Research
• 1 - 100 Employee

• Chief Executive Officer

  • Jul 2020 - Present

  Leading the development of Australia’s most technologically advanced viral vector vaccine platform and a new global vaccine platform to tackle complex disease pathogens. Leading the development of Australia’s most technologically advanced viral vector vaccine platform and a new global vaccine platform to tackle complex disease pathogens.



University of South Australia

• Australia
• Higher Education
• 700 & Above Employee

• Adjunct Senior Industry Fellow

  • Sep 2020 - Present

  Dept of Clinical & Health Sciences Dept of Clinical & Health Sciences



Leanne Hobbs Consulting

• Independent Consultant

  • Jan 2020 - Jan 2021

  Expert in Vaccine and Pharmaceutical late stage development, market access and commercialisation strategy and execution with P&L management experience; insight and experience across all major global markets and expansive understanding of the healthcare environment from Govt to NGO to Physician to Patient; strong situational leader with experience in growth/turnaround/divestment and crisis management. Personally driven by growth and continuous improvement and making a positive, responsible impact on the world.



BIO4WARD

• France
• Biotechnology Research
• 1 - 100 Employee

• Partner, Market Access & Commercialisation

  • Apr 2017 - Jan 2021

  Bio4ward is a unique combination of the experience and professionalism from major companies and the start-up culture and pragmatism to the service of innovative life sciences companies. Specifically I provide expertise in market access and commercialisation strategy, B2B marketing and partnerships and sales strategy and planning. Bio4ward is a unique combination of the experience and professionalism from major companies and the start-up culture and pragmatism to the service of innovative life sciences companies. Specifically I provide expertise in market access and commercialisation strategy, B2B marketing and partnerships and sales strategy and planning.



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Global Vaccines Commercialisation Leader (VCL) and Global Head HPV Vaccines

  • Jul 2014 - Apr 2016

  General management and P&L accountability for GSK's global HPV vaccine franchise. Leadership of a senior cross functional team to develop and implement the global commercial, manufacturing and supply, medical and R&D strategy for the HPV vaccine portfolio within GSK. Member of the commercial leadership team for GSK vaccines, reporting to the SVP Commercial and Vaccines Executive Team.

• Senior Director, Global Commecial Lead DTP/Polio/Neisseria Vaccines

  • Jan 2010 - Jul 2014

  Leadership of the commercial team responsible to develop and implement the global commercial strategy for GSKs largest vaccine portfolio, including ongoing commercialisation, supply chain and life cycle management of Infanrix and Boostrix; the future DTPw vaccine strategy and joint venture with Bio-E; the Polio vaccine strategy and the meningitis vaccine portfolio including Mencevax life cycle management and preparation of the global Nimenrix launch.

• National Sales and Marketing Manager, Adolescent and Adult Vaccines

  • Jan 2009 - Jan 2010

  Managing the Australian business unit, with responsibility for the sales and marketing teams promoting GSK's travel vaccine portfolio; cervical cancer and private market pertussis booster vaccines and supporting GSK's flu and government/tender vaccine business

• National Marketing Manager, Vaccines

  • Oct 2007 - Dec 2008

  Leadership of the marketing team responsible for access and commercialisation of GSK's public market (government tender) vaccine portfolio including Vaccines for DTP/HepatitisB/Hib and Polio; Rotavirus; Measles/Mumps/Rubella and Varicella in Australia.

• Brand Manager (Cervarix)

  • Sep 2005 - Sep 2007

  Responsible for first global launch of Cervarix, a vaccine for the prevention of cervical cancer, with specific responsibility for professional communications; public relations and patient advocacy.

• New Products Manager

  • Sep 2004 - Aug 2005

  Strategic analysis and planning for market access and commercialisation of GSK's pharmaceutical and vaccine portfolio in the Australian market and contribution to global clinical and commercial planning processes.

• Health Economics and Outcomes Research Specialist

  • Mar 2000 - Aug 2004

  Economic and clinical analysis of GSK's pharmaceutical products to facilitate reimbursement by the Australian government. Engagement with key external experts and government stakeholders to support reimbursement submissions. Pricing analysis and input into global clinical and health outcomes programmes for GSK portfolio. Outcomes research in collaboration with Australian research centres.

• Regulatory Affairs Specialist (International)

  • Apr 1997 - Feb 2000

  Preparation of regulatory dossiers and data to support registration of GSK consumer (incl Panadol and Aquafresh) and pharmaceutical products (Diabetes and Cardiovascular) to support market access in South East Asia; Latin America; Middle East and Africa. Analysis and communication of key global regulatory policy evolution and requirement changes.

• Regulatory Affairs Associate (Consumer Healthcare)

  • Mar 1996 - Mar 1997

  Responsible for supporting manufacturing facilities integration process and regulatory dossier and data requirements in support of global Panadol franchise.



Flinders University

• Australia
• Higher Education
• 700 & Above Employee

• NH&MRC Research Assistant, Dept of Biochemistry

  • Mar 1995 - Dec 1995